Premium Reports
Contact KLAS
 Download Report Brief  Download Full Report    Zoom in charts



Related Series

Epic Pharmacy Solutions 2020
IV Compounding 2019
IV Compounding 2017
IV Robots & Workflow Management 2014
U.S. IV Automation

Related Segments

 End chart zoom
Gravimetric Verification In IV Workflow Management 2021 Gravimetric Verification In IV Workflow Management 2021
* A page refresh may be necessary to see the updated image

Gravimetric Verification In IV Workflow Management 2021
How Has The Market Progressed?

author - Jackson Tate
Jackson Tate
author - Paul Warburton
Paul Warburton
July 6, 2021 | Read Time: 6  minutes

Current Time Inside Cache Tag Helper: 6/10/2023 6:09:12 AM and Model.reportId = 1788

Gravimetric verification has been touted as a way to drive significant patient safety gains, and most major IV workflow management vendors have released this functionality. However, the associated challenges (e.g., maintaining an accurate drug density database, changes to compounding workflows) have hurt perceived value for some healthcare organizations, and so far, only BD has demonstrated broad deployment in their customer base. This report examines the maturity of vendors’ gravimetric verification functionality, provides a first look at BD’s performance in this area, and assesses how the technology affects purchase decisions across the market.

to see the full dataset.

if you don't have a login, getting started is easy.

Provider Organizations
Fill out our registration form to verify your organization.
HIT Companies
Contact a KLAS representative for plans and pricing.
Current Time Inside Cache Tag Helper: 6/10/2023 6:09:12 AM and Model.reportId = 1788

Key Findings:

  1. BD Far Outpaces Competitors in Rolling Out Gravimetric Verification to Customers
  2. BD Seen as Pioneer with Gravimetric Verification Adoption Push; Customers Need More Help Navigating the Learning Curve
  3. Grifols’ Stable Technology and Responsive Support Drive Satisfaction
  4. Buying Energy: Lack of Gravimetric Verification Proof Points Limits Baxter, Epic, Grifols & Omnicell
author - Amanda Wind Smith
Amanda Wind Smith
author - Jess Wallace-Simpson
Jess Wallace-Simpson
author - Isaac Burgi
Project Manager
Isaac Burgi
 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2023 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.

Related Segments